BMY FY 2025 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$124B

FY 2025 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$48.2B-0.2% YoY

Gross Profit

$32.6B67.6% margin

Operating Income

$12.7B26.3% margin

Net Income

$7.1B14.6% margin

EPS (Diluted)

$3.45

Cash Flow

Operating Cash Flow

$14.2B

Free Cash Flow

$12.8B

Stock-Based Comp.

$553M

Balance Sheet

Total Assets

$90.0B

Total Liabilities

$71.5B

Stockholders' Equity

$18.5B

Cash & Equivalents

$10.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48.2B	$48.3B	-0.2%
Gross Profit	$32.6B	$27.4B	+18.8%
Operating Income	$12.7B	$9.7B	+31.5%
Net Income	$7.1B	-$8.9B	+178.8%